Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

International Stem Cell (ISCO) Return on Sales (2016 - 2025)

International Stem Cell (ISCO) has disclosed Return on Sales for 16 consecutive years, with 0.01% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Sales rose 5.0% to 0.01% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.01%, a 7.0% increase, with the full-year FY2024 number at 0.02%, up 8.0% from a year prior.
  • Return on Sales was 0.01% for Q3 2025 at International Stem Cell, down from 0.04% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.05% in Q2 2024 to a low of 0.36% in Q1 2021.
  • A 5-year average of 0.1% and a median of 0.07% in 2023 define the central range for Return on Sales.
  • Peak YoY movement for Return on Sales: soared 36bps in 2022, then fell -25bps in 2023.
  • International Stem Cell's Return on Sales stood at 0.2% in 2021, then soared by 106bps to 0.01% in 2022, then plummeted by -2204bps to 0.24% in 2023, then skyrocketed by 102bps to 0.0% in 2024, then plummeted by -350bps to 0.01% in 2025.
  • Per Business Quant, the three most recent readings for ISCO's Return on Sales are 0.01% (Q3 2025), 0.04% (Q2 2025), and 0.1% (Q1 2025).